[德国眼科医生专业协会（BVA）、德国眼科学会（DOG）和视网膜病学会（RG）关于中心性浆液性脉络膜视网膜病变的声明：2021年10月18日状况] - Suppr

Suppr

超能文献

[Statement of the Professional Association of Ophthalmologists in Germany (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on central serous chorioretinopathy : Status 18 October 2021].

出版信息

Ophthalmologe. 2022 Feb;119(2):148-162. doi: 10.1007/s00347-021-01549-4. Epub 2021 Dec 14.

DOI:10.1007/s00347-021-01549-4

PMID:34905071

Abstract

摘要

相似文献

[Statement of the Professional Association of Ophthalmologists in Germany (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on central serous chorioretinopathy : Status 18 October 2021].[德国眼科医生专业协会（BVA）、德国眼科学会（DOG）和视网膜病学会（RG）关于中心性浆液性脉络膜视网膜病变的声明：2021年10月18日状况]

Ophthalmologe. 2022 Feb;119(2):148-162. doi: 10.1007/s00347-021-01549-4. Epub 2021 Dec 14.

Statement of the Professional Association of Ophthalmologists in Germany (BVA), the German Society of Ophthalmology (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Status 18 October 2021.德国眼科医生专业协会（BVA）、德国眼科学会（DOG）和德国视网膜协会（RG）关于中心性浆液性脉络膜视网膜病变的声明：2021年10月18日的情况

Ophthalmologie. 2022 Jul;119(Suppl 2):108-122. doi: 10.1007/s00347-022-01614-6. Epub 2022 Apr 6.

[Statement and recommendation of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Situation January 2018].[德国眼科医生专业协会（BVA）、德国眼科学会（DOG）和德国视网膜协会（RG）关于中心性浆液性脉络膜视网膜病变的声明与建议：2018年1月情况]

Ophthalmologe. 2018 May;115(5):388-399. doi: 10.1007/s00347-018-0680-6.

Statement of the Professional Association of German Ophthalmologists (BVA), the German Society of Ophthalmology (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Situation January 2018.德国眼科医生专业协会（BVA）、德国眼科学会（DOG）和德国视网膜协会（RG）关于中心性浆液性脉络膜视网膜病变的声明：2018年1月的情况

Ophthalmologe. 2019 Feb;116(Suppl 1):10-20. doi: 10.1007/s00347-018-0809-7.

[Statement of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on the development, diagnostics and treatment of epiretinal gliosis : Status October 2020].[德国眼科医生专业协会（BVA）、德国眼科学会（DOG）和视网膜病学会（RG）关于视网膜前胶质增生的发展、诊断和治疗的声明：2020年10月状况]

Ophthalmologe. 2021 Feb;118(2):121-138. doi: 10.1007/s00347-020-01291-3.

Statement of the German Ophthalmological Society (DOG), the Retinological Society (RG) and the Professional Association of Ophthalmologists in Germany (BVA) on the timing of treatment of rhegmatogenous retinal detachment : Dated October 2020.德国眼科学会（DOG）、视网膜病学会（RG）和德国眼科医生专业协会（BVA）关于孔源性视网膜脱离治疗时机的声明：日期为2020年10月。

Ophthalmologe. 2021 Jul;118(Suppl 2):132-134. doi: 10.1007/s00347-021-01440-2. Epub 2021 Jul 7.

[Statement of the German Ophthalmological Society (DOG), the Retinological Society (RG) and the Professional Association of Ophthalmologists in Germany (BVA) on the timing of treatment of rhegmatogenous retinal detachment : Situation October 2020].[德国眼科学会（DOG）、视网膜病学会（RG）和德国眼科医生专业协会（BVA）关于孔源性视网膜脱离治疗时机的声明：2020年10月情况]

Ophthalmologe. 2021 Mar;118(3):235-238. doi: 10.1007/s00347-020-01311-2. Epub 2021 Jan 18.

[Supplementary statement of the German Ophthalmological Society (DOG), the Retinological Society (RG) and the Professional Association of German Ophthalmologists (BVA) on treatment of proliferative diabetic retinopathy : Status November 2019].[德国眼科学会（DOG）、视网膜病学会（RG）和德国眼科医生专业协会（BVA）关于增殖性糖尿病视网膜病变治疗的补充声明：2019年11月状况]

Ophthalmologe. 2020 Aug;117(8):755-759. doi: 10.1007/s00347-020-01116-3.

[Supplementary statement of the German Professional Association of Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on laser treatment of drusen in age-related macular degeneration (AMD) : Status October 2018].[德国眼科医生专业协会（BVA）、德国眼科学会（DOG）和视网膜病学会（RG）关于年龄相关性黄斑变性（AMD）中玻璃疣激光治疗的补充声明：2018年10月状况]

Ophthalmologe. 2019 Feb;116(2):138-143. doi: 10.1007/s00347-018-0834-6.

[Statement of the German Ophthalmological Society (DOG), the Retinological Society (RG) and the Professional Association of German Ophthalmologists (BVA) on the treatment of disturbing degenerative vitreous opacities : Status 20 November 2019].[德国眼科学会（DOG）、视网膜病学会（RG）和德国眼科医生专业协会（BVA）关于令人困扰的退行性玻璃体混浊治疗的声明：2019年11月20日情况]

Ophthalmologe. 2020 Jul;117(7):668-670. doi: 10.1007/s00347-020-01115-4.

本文引用的文献

Macular and submacular choroidal microvasculature in patients with primary open-angle glaucoma and high myopia.原发性开角型青光眼和高度近视患者的黄斑及黄斑下脉络膜微血管系统

Br J Ophthalmol. 2023 May;107(5):650-656. doi: 10.1136/bjophthalmol-2021-319557. Epub 2021 Dec 10.

Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders.静脉超负荷性脉络膜病变：中心性浆液性脉络膜视网膜病变及相关疾病的一个假说框架

Prog Retin Eye Res. 2022 Jan;86:100973. doi: 10.1016/j.preteyeres.2021.100973. Epub 2021 May 21.

Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser.光动力疗法或微脉冲激光成功治疗慢性中心性浆液性脉络膜视网膜病变的长期随访。

Acta Ophthalmol. 2021 Nov;99(7):805-811. doi: 10.1111/aos.14775. Epub 2021 Feb 10.

Eplerenone for chronic central serous chorioretinopathy.依普利酮用于慢性中心性浆液性脉络膜视网膜病变

Lancet. 2020 Nov 14;396(10262):1556. doi: 10.1016/S0140-6736(20)31610-X.

Optimal fluence rate of photodynamic therapy for chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变光动力疗法的最佳光密度。

Br J Ophthalmol. 2021 Jun;105(6):844-849. doi: 10.1136/bjophthalmol-2020-316837. Epub 2020 Jul 29.

Systemic Corticosteroid Use after Central Serous Chorioretinopathy Diagnosis.诊断为中心性浆液性脉络膜视网膜病变后使用全身皮质类固醇。

Ophthalmology. 2021 Jan;128(1):121-129. doi: 10.1016/j.ophtha.2020.06.056. Epub 2020 Jun 30.

Analysis of choriocapillaris perfusion and choroidal layer changes in patients with chronic central serous chorioretinopathy randomised to micropulse laser or photodynamic therapy.分析慢性中心性浆液性脉络膜视网膜病变患者脉络膜毛细血管灌注和脉络膜层变化，随机分为微脉冲激光或光动力治疗组。

Br J Ophthalmol. 2021 Apr;105(4):555-560. doi: 10.1136/bjophthalmol-2020-316076. Epub 2020 Jun 12.

Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy.急性中心性浆液性脉络膜视网膜病变的复发风险及向慢性病的转变

Clin Ophthalmol. 2020 Apr 29;14:1165-1175. doi: 10.2147/OPTH.S242926. eCollection 2020.

OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY-GUIDED PHOTODYNAMIC THERAPY FOR ACUTE CENTRAL SEROUS CHORIORETINOPATHY.光学相干断层扫描血管造影引导光动力疗法治疗急性中心性浆液性脉络膜视网膜病变。

Retina. 2021 Jan 1;41(1):189-198. doi: 10.1097/IAE.0000000000002795.

Swept-source optical coherence tomography angiography alleviates shadowing artifacts caused by subretinal fluid.扫频源光学相干断层扫描血管造影减轻了视网膜下液引起的遮蔽伪影。

Int Ophthalmol. 2020 Aug;40(8):2007-2016. doi: 10.1007/s10792-020-01376-7. Epub 2020 Apr 24.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验